A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients

Clinical trial NCT01324128 · COMPLETED

Trial details

NCT number: NCT01324128
Sponsor: Vifor Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Kidney Disease Requiring Chronic Dialysis

Start date: 2011-03-01
Primary completion: 2012-04-01
Enrollment: 1059

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.